Quantcast

Latest Montreal Heart Institute Stories

2014-02-19 08:30:28

MONTREAL, Feb. 19, 2014 /PRNewswire/ - The Montreal Heart Institute (MHI) announced last week the launch of ARTERIA, a research program aimed at developing ground-breaking treatments for cardiovascular diseases, the number one cause of death worldwide. "Once again, the Montreal Heart Institute and its team of dedicated physicians, researchers and professionals have established themselves as world leaders in the fight against heart disease. This program will have tangible positive...

2014-02-14 16:25:21

MONTREAL, Feb. 14, 2014 /PRNewswire/ - In the presence of Quebec Premier, Pauline Marois, ministers Nicolas Marceau, Jean-François Lisée and Élaine Zakaïb, Montreal Mayor, Denis Coderre, and the representatives of international pharmaceutical companies, Dr. Jean-Claude Tardif, Director of the Research Centre of the Montreal Heart Institute (MHI), announced today the launch of ARTERIA, a research program aimed at developing ground-breaking treatments for cardiovascular...

2012-03-17 00:02:02

A clinical study co-led by the Montreal Heart Institute and Innovaderm Research Inc., which was presented today at the annual meeting of the American Academy of Dermatology, shows that a new treatment for psoriasis could be associated with a significant decrease in vascular inflammation, a major risk factor of cardiovascular disease. Psoriasis is a chronic inflammatory disease of the skin and joints that affects up to 3% of the population. This disease is associated with a greater risk of...

2011-12-05 10:57:30

The interventional cardiology team at the Montreal Heart Institute (MHI) used the world's first drug eluting bioresorbable vascular scaffold to successfully treat a woman suffering from coronary artery disease. This landmark procedure was performed by Dr. Jean-François Tanguay, interventional cardiologist and coordinator of the Coronary Unit, as part of the ABSORB EXTEND clinical trial. This successful intervention was a first in North America. A breakthrough that could change...

2011-07-28 17:44:30

The findings of a Montreal Heart Institute (MHI) study published in the scientific journal Cardiology suggest that ivabradine, a heart rate reduction medication, is also effective in reducing the risk of diastolic heart failure (left ventricular insufficiency) and cardiac fibrosis. The benefits of slower heart rate on mortality and morbidity associated with cardiovascular disease no longer need to be demonstrated. In this study, titled "Heart Rate Reduction by Ivabradine Reduces Diastolic...

2011-05-11 13:45:13

The electrophysiology team at the Montreal Heart Institute (MHI) used cryoablation (ablation using cold) to treat a patient suffering from atrial fibrillation, the most common form of cardiac arrhythmia, and one associated with significant morbidity. The procedure was performed by Dr. Peter Guerra, Chief of Electrophysiology, and Dr. Marc Dubuc, cardiologist and specialist in electrophysiology. This was a first in Canada following the approval of the Arctic Front device by Health Canada. A...

2011-04-14 15:31:57

The Montreal Heart Institute participates to an initial experiment with personalized antiplatelet therapy An international consortium of scientists, including major contributions from the Montreal Heart Institute, demonstrates that the "one-size fits all" strategy of uniformly doubling the dose of an antiplatelet drug, clopidogrel, for patients with high on-treatment platelet reactivity does not reduce the incidence on death, heart attacks and stent thrombosis after percutaneous coronary...

2011-02-25 12:22:52

Successful initiation of trial for new device designed to treat patients who suffer from refractory angina The interventional cardiology team at the Montreal Heart Institute (MHI) recently began patient enrolment for a new device, the Neovasc ReducerTM, designed to treat patients suffering from refractory angina. The treatment method is a first in North America and is being conducted as part of an international study, the COSIRA trial. This innovative treatment is promising for thousands of...

2010-11-11 22:07:46

New study published in Journal of Cardiopulmonary Rehabilitation and Prevention People affected by anxiety and depression should receive an additional cardiac test when undergoing diagnosis for potential heart problems, according to a new study from Concordia University, the Universit© du Qu©bec à Montr©al and the Montreal Heart Institute. As part of this study, published in the Journal of Cardiopulmonary Rehabilitation and Prevention, a large sample of...

2010-10-25 13:01:44

Levels of anxiety sensitivity may be important in choosing medical treatment for patients with heart failure and atrial fibrillation (AF), Montreal Heart Institute researchers today told the Canadian Cardiovascular Congress 2010, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society. Heart and Stroke Foundation researcher and lead author Nancy Frasure-Smith, PhD explained that anxiety sensitivity is the degree to which a person is frightened by bodily sensations...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.